Literature DB >> 2912333

The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage.

J A Pang1, A Cheng, H S Chan, D Poon, G French.   

Abstract

Bacteria often colonize the lower respiratory tract of patients with bronchiectasis. Although the role of these bacteria in the pathogenesis of the disease is uncertain, their accurate identification is important for epidemiologic and treatment purposes. Therefore, the aims of this study were: (1) to identify these bacteria in patients with bronchiectasis without cystic fibrosis using the protected catheter brush (PCB) in order to avoid oropharyngeal contamination, and (2) to compare the results of bronchoalveolar lavage (BAL) with PCB. Quantitative culture was performed on PCB and BAL specimens obtained from the most severely affected lobes of 23 patients with bronchiectasis. Results of PCB showed no significant growth (less than 10(3) colony-forming units [cfu]/ml) in nine patients and 17 significant isolates (greater than 10(3) cfu/ml) in the rest: H. influenzae, 5; P. aeruginosa, 4; K. ozaenae, 2; S. aureus, 2; P. fluorescens, 1; S. pneumoniae, 1; Veillonella, 1; and coag.-ve Staph., 1. For BAL, the results were the same (20 isolates) regardless of whether 10(4) or 10(5) cfu/ml was chosen as the cutoff point. More organisms were cultured from BAL specimens, and these included all but one of the organisms cultured from PCB. We conclude that the bacteriology of bronchiectasis in Hong Kong is different from that reported in sputum studies in the West (mainly H. influenzae, S. pneumoniae, and S. aureus), and with 10(4) cfu/ml as the cutoff point, BAL gives comparable results to PCB.

Entities:  

Mesh:

Year:  1989        PMID: 2912333     DOI: 10.1164/ajrccm/139.1.14

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.

Authors:  J Angrill; C Agustí; R de Celis; A Rañó; J Gonzalez; T Solé; A Xaubet; R Rodriguez-Roisin; A Torres
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

Review 2.  Evaluation of the available invasive and non-invasive techniques for diagnosing nosocomial pneumonias in mechanically ventilated patients.

Authors:  A Torres; J González; M Ferrer
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Recurrent infections and chronic colonization by an Escherichia coli clone in the respiratory tract of a patient with severe cystic bronchiectasis.

Authors:  J Y Wang; P R Hsueh; J T Wang; L N Lee; P C Yang; K T Luh
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Simple method for quantifying viable bacterial numbers in sputum.

Authors:  A Pye; R A Stockley; S L Hill
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

5.  Mycobacteria as a cause of infective exacerbation in bronchiectasis.

Authors:  C H Chan; A K Ho; R C Chan; H Cheung; A F Cheng
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

6.  Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis.

Authors:  Heather Maughan; Kristopher S Cunningham; Pauline W Wang; Yu Zhang; Marcelo Cypel; Cecilia Chaparro; D Elizabeth Tullis; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu; David S Guttman; David M Hwang
Journal:  Pulm Med       Date:  2012-02-08

Review 7.  Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.

Authors:  Xia-Yi Miao; Xiao-Bin Ji; Hai-Wen Lu; Jia-Wei Yang; Jin-Fu Xu
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

8.  The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology.

Authors:  John E Moore; John McCaughan; Jacqueline C Rendall; Beverley C Millar
Journal:  Br J Biomed Sci       Date:  2022-06-08       Impact factor: 2.432

Review 9.  Infections in chronic lung diseases.

Authors:  G Iyer Parameswaran; Timothy F Murphy
Journal:  Infect Dis Clin North Am       Date:  2007-09       Impact factor: 5.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.